(ASTC) Astrotech - Ratings and Ratios

Astrotech Corporation (NASDAQ:ASTC) is a global leader in mass spectrometry technology, specializing in the development and commercialization of advanced detection and analysis solutions. The companys core technology, the Astrotech Mass Spectrometer Technology, serves as a versatile platform for various applications across security, agriculture, and healthcare. Astrotechs product portfolio includes the TRACER 1000, a next-generation explosive trace detector designed to enhance security screening at airports, borders, and critical infrastructure; the AGLAB-1000, a specialized mass spectrometer for the hemp and cannabis industry; the BreathTest-1000, a non-invasive breath analysis tool for detecting volatile organic compounds; and the Pro-Control 1000-D2, a high-precision mass spectrometer for industrial and laboratory use. Formerly known as SPACEHAB, Inc., the company rebranded as Astrotech Corporation in 2009 to reflect its expanded focus on mass spectrometry and related technologies. Headquartered in Austin, Texas, Astrotech has been innovating since its incorporation in 1984.

From a technical perspective, ASTC is currently trading at $6.52 with a 20-day moving average of $6.51 and a 50-day moving average of $6.70. The stocks 200-day moving average stands at $7.99, indicating a recent downtrend. Average daily trading volume is approximately 1,988 shares, with an ATR of 0.36, suggesting low volatility. On the fundamental side, the company has a market cap of $11.13 million, a price-to-book ratio of 0.39, and a price-to-sales ratio of 26.56. The return on equity is -47.70, reflecting current profitability challenges.

3-Month Forecast: - Price Action: Expect ASTC to trade within a narrow range, with potential resistance at $7.00 and support at $6.00. The convergence of the 20-day and 50-day moving averages suggests short-term stability. - Volume: Average daily volume is likely to remain low, indicating limited market participation. - Momentum: The stock may face headwinds due to the negative return on equity and high price-to-sales ratio, which could deter investors seeking growth opportunities. - Catalysts: Any positive developments in the companys product pipeline or partnerships could act as upside catalysts, while continued losses may pressure the stock lower.